INO-5150, an active immunotherapy
targeting both PSA and PSMA antigens which are present in the majority of prostate cancer cells, is administered with and without INO-9012, Inovios DNA-based IL-12 immune activator.
Listed on Alternext Paris since 2010, Neovacs is a biotechnology company focused on an active immunotherapy
technology platform (Kinoids) with applications in autoimmune and/or inflammatory diseases.
In terms of active immunotherapy
and the type of technology we're developing, they've undergone an evolution in the last three or four years.
B-cell malignancies are good candidates for active immunotherapy
The CAS found no differences in asthma symptoms between the active immunotherapy
and placebo groups.
In the best of situations, I would expect only 25%-30% of people in this older age group with Alzheimer's would be likely to mount sufficient antibody response to remove plaques with active immunotherapy
," he said.
This novel peptide is significant because it could provide the basis for an active immunotherapy
that uses T-cells to attack and destroy cancer cells that overexpress the HER-2 antigen," stated Gail Maderis, president of Genzyme Molecular Oncology.
Coley's work is a primitive example of what today is known as active immunotherapy
, wherein patients are given something designed to activate their immune system against cancer.
UNS' ongoing Phase 2 active immunotherapy
trial of UB-311 in early-to-mild AD patients is fully enrolled.
INO-3112, an active immunotherapy
targeting HPV 16/18 combined with a DNA plasmid for IL-12 as an immune activator, is designed to activate patients immune responses to specifically target and kill HPV associated tumors.
Researchers hypothesize that reducing alpha-synuclein accumulation will be neuroprotective; Affiris is using active immunotherapy
to test that theory and develop a disease-modifying treatment.